[HTML][HTML] Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou, Q Wu, B Lu… - Journal of Hematology & …, 2023 - Springer
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

[HTML][HTML] Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou… - … of Hematology & …, 2023 - jhoonline.biomedcentral.com
The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a, which mediates
antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and non-cleavable …

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou… - … of hematology & …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.

F Meng, S Zhang, J Xie, Y Zhou, Q Wu, B Lu… - … of Hematology & …, 2023 - europepmc.org
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou, Q Wu… - … of Hematology & …, 2023 - search.proquest.com
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

[HTML][HTML] Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou, Q Wu… - … of Hematology & …, 2023 - ncbi.nlm.nih.gov
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.

F Meng, S Zhang, J Xie, Y Zhou, Q Wu… - … of Hematology & …, 2023 - search.ebscohost.com
Background: The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

[PDF][PDF] Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

F Meng, S Zhang, J Xie, Y Zhou… - … of Hematology & …, 2023 - jhoonline.biomedcentral.com
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibodydependent cell-mediated cytotoxicity (ADCC). The high-affinity and …

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.

F Meng, S Zhang, J Xie, Y Zhou, Q Wu, B Lu… - … of Hematology & …, 2023 - europepmc.org
Background The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a,
which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and …